Welcome to
On Feet Nation
smithmorgan Online
Grace Online
Helen Online
Lovina Lindy Online
Posted by smithmorgan on August 22, 2024 at 6:51pm 0 Comments 0 Likes
Posted by smithmorgan on August 22, 2024 at 6:51pm 0 Comments 0 Likes
Posted by smithmorgan on August 22, 2024 at 6:50pm 0 Comments 0 Likes
The global Phenylketonuria Treatment Market is expected to grow by the year 2030 at a CAGR of 7%. Healthcare systems have been basically emphasizing on affordability as well as quality of the medical services. However, now, digitization has come through, which would drive revolution in the same healthcare vertical. The life sciences would go digitally innovative. This would be the way healthcare vertical would go in the next 10 years.
Phenylketonuria (PKU) is an inherited disorder caused by excess of phenylalanine in the blood, which can lead to severe intellectual disabilities. There is no cure for phenylketonuria as yet, and dietary management is the only option to maintain the phenylalanine level in the body. Untreated infants with PKU tend to have unusually light eye, skin, and hair colour due to excess of phenylalanine levels interfering with melanin. Neurological symptoms such as seizures, abnormal muscle movement, tremors, or involuntary movement are some of the symptoms mainly observed in such patients.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/14410
Rising prevalence of phenylketonuria among newborns and surging demand for novel formulations to treat the disease have led to increased opportunities for market players. Stakeholders are investing more in research & development for novel treatment solutions within the nutraceutical industry.
According to the latest report published by Persistence Market Research, the global phenylketonuria treatment market for protein ingredients was valued at US$ 325.9 Mn in 2019, and is predicted to witness an impressive CAGR of over 6% during the forecast period (2020–2030). Similarly, the market for finished products was valued at US$ 565.8 Mn in 2019, and is predicted to witness an impressive CAGR of around 7% through 2030.
Company Profiles:
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/14410
www.persistencemarketresearch.com/images/phenylketonuria-treatment-market.jpg?w=1200&ssl=1" alt="phenylketonuria-treatment-market" data-recalc-dims="1" data-lazy-loaded="1" />
Key Takeaways from Phenylketonuria Treatment Market Study
For Protein Ingredients
For Finish Products
“Increasing prevalence of PKU and rising adoption of PKU diets will upswing the global phenylketonuria treatment market over the coming years,” says an analyst of Persistence Market Research.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/14410
Collaborations & Acquisitions Key Strategies amongst Market Players
Prominent players in the phenylketonuria treatment market are firming their product ranges through acquisitions and reaching out to emerging markets. Increasing investments and manufacturing capacity expansion are expected to favour growth of the global market over the forecast period.
Various players in the phenylketonuria treatment market are focusing on research & development, product launches, and advanced solutions to strengthen and expand their product portfolios.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the phenylketonuria treatment market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030. The research study is based on PKU ingredients (protein ingredient [Glycomacropeptide (GMP) and essential and non-essential amino acids] and finish products [Glycomacropeptide (GMP) and essential and non-essential amino acids]), targeted customer (protein ingredients [consumer healthcare companies, pharmaceutical companies, and contract manufacturing companies (CMOs)] and finish products [adults, paediatrics, and pregnant women]), form (protein ingredients [powder blend and granules], finish products [powder & granules, tablets, capsules, powder sachets, ready-to-drink, shakes, and other]), and sales channel (protein ingredients [industry sales], finish products [hospital pharmacies, retail pharmacies, online pharmacies, and hypermarkets & supermarkets]), across seven key regions of the world.
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation